HRA® offers compensation of $750 to physicians for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey.

Please note: this is a non-CME, unsponsored program. All content is independently developed by the NeurologyLive® team.

OVERVIEW

NeurologyLive® Clinical Forum are regional roundtable discussions where an expert moderator has the opportunity to directly engage with neurologists to present data, medical advances, and patient case scenarios. This leads to a moderated forum between attendees to gather insights on their community practice implementation of new science, feedback on case scenarios, as well as other information which impact the clinical decision making of local neurologists.

These forums serve as a platform for localized education and peer-to-peer collaborative discussions aiming to ultimately elevate and improve patient care. 

LEARNING OBJECTIVES

• Understand use of high efficacy therapies in multiple sclerosis.
• Highlight differences between anti-CD20 disease modifying therapies and examine their use in clinical practice.
• Evaluate MS treatment selection criteria for patients of different ages.

This event is held in partnership with Healthcare Research & Analytics (HRA®) to gain market research insights into health care professional’s educational needs in their current practice setting.   

HRA® offers compensation of $750 to physicians for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey. 

Copyright NeurologyLive 2025.

All Rights Reserved.

Terms & Conditions

Privacy Policy

Contact Us: events@neurologylive.com